ABSTRACT
COVID-19 can present with respiratory symptoms ranging from mild cough to viral pneumonia and ARDS. Lung ultrasonography has emerged as a promising imaging modality during the pandemic, but there is still a paucity of systematic analysis of lung ultrasound findings.
In this retrospective observational study, 12 Zone ultrasound scans of COVID-19 positive patients were systematically analysed for pleural irregularities, subpleural consolidations, B lines, deep consolidations and effusions. Lung abnormalities were analysed according to overall frequency, frequency distribution in coronal and sagittal lung planes and were also correlated to clinical severity groups as determined by oxygenation deficit.
Our results show that lung zones with abnormalities can occur juxtaposed to normal lung. Irregular pleural and small subpleural consolidations appear ubiquitously distributed throughout both lungs and occur early in the disease process. Wide B-lines are a predominant feature in COVID-19 infection. B-lines are found in a variety of patterns with number and width correlated to disease severity. In our analysis we also describe a previously unrecognised finding of small peri-pleural effusions in 8.7% of scans occurring in all areas of the lung.
The current results form the basis for a more thorough understanding of the lung changes occurring in COVID-19 and the incorporation of lung ultrasound in the setting of COVID-19 infection including triage, diagnosis, treatment approach and prognosis.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
The study is not a clinical trial, but a retrospective observational study using investigations as part of routine assessment
Funding Statement
No external funding was received for this study
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRAS 286015 HRA approved - REC reference: 20/HRA/3386
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
all data is provided in the article